Selected Publications1. Jahan R, Stewart D, Vinters HV, Yong W, Vinuela F, Vandeberg P, Marder VJ. Middle Cerebral Artery Occlusion in the Rabbit Using Selective Angiography. Application for Assessment of Thrombolysis. Stroke. 2008 Mar 13; (2008).
2. Marder VJ. Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator. Thromb Res. 122 Suppl 3:S9-S15 (2008).
3. Jahan R, Stewart D, Vinters HV, Yong W, Vinuela F, Vandeberg P, Marder VJ. Middle cerebral artery occlusion in the rabbit using selective angiography: application for assessment of thrombolysis. Stroke. 39(5):1613-5 (2008).
4. Yue W, Schneider A, Ruckerl R, Koenig W, Marder V, Wang S, Wichmann HE, Peters A, Zareba W. Relationship between electrocardiographic and biochemical variables in coronary artery disease. Int J Cardiol. 119(2):185-91 (2007).
5. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Vespa PM, Selco S, Rajajee V, Kim D, Sanossian N, Saver JL. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke. 37(8):2086-93 (2006).
6. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Vespa PM, Selco S, Rajajee V, Kim D, Sanossian N, Saver JL. Analysis of Thrombi Retrieved From Cerebral Arteries of Patients With Acute Ischemic Stroke. Stroke. 2006 Jun 22; (2006).
7. Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich J, Marder V, Frampton M, Wichmann HE, Peters A. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med. 173(4):432-41 (2006).
8. Bussey HI, Tapson V, Cannon RO 3rd, Nolan PE Jr, Gage B, Penzak SR, Spinler SA, De Smet P, Wittkowsky A, Lee AP, Ernst E, Marder VJ. Opinions and research priorities. Thromb Res. 117(1-2):155-69; discussi (2005).
9. Marder VJ. The interaction of dietary supplements with antithrombotic agents: scope of the problem. Thromb Res. 117(1-2):7-13; discussion (2005).
10. Hull RD, Marder VJ, Mah AF, Biel RK, Brant RF. Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: a systematic review. Am J Med. 118(5):456-64 (2005).
11. Hasan AA, Marder VJ. Conference summary and recommendations for research. Thromb Res. 117(1-2):229-30 (2005).
12. Warkentin TE, Cook RJ, Marder VJ, Sheppard JA, Moore JC, Eriksson BI, Greinacher A, Kelton JG. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood. 106(12):3791-6 (2005).
13. Novokhatny VV, Jesmok GJ, Landskroner KA, Marder VJ, Zimmerman TP. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?. Trends Pharmacol Sci. 25(2):72-5 (2004).
14. Marder VJ, Rosove MH, Minning DM. Foundation and sites of action of antithrombotic agents. Best Pract Res Clin Haematol. 17(1):3-22 (2004).
15. Pineo G, Hull R, Marder V. Oral delivery of heparin: SNAC and related formulations. Best Pract Res Clin Haematol. 17(1):153-60 (2004).
16. Narins CR, Zareba W, Moss AJ, Marder VJ, Ridker PM, Krone RJ, Lichstein E. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med. 164(4):440-6 (2004).
17. Corsetti JP, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rainwater DL, Sparks CE. Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients. Atherosclerosis. 171(2):351-8 (2003).
18. Harb TS, Zareba W, Moss AJ, Ridker PM, Rifai N, Marder VJ, Miller-Watelet L. Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients. Am J Cardiol. 91(9):1120-3 (2003).
19. Stewart D, Kong M, Novokhatny V, Jesmok G, Marder VJ. Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage. Blood. 101(8):3002-7 (2003).
20. Fadl YY, Zareba W, Moss AJ, Marder VJ, Sparks CS, Miller Watelet LF, Carroll ER. History of hypertension and enhanced thrombogenic activity in postinfarction patients. Hypertension. 41(4):943-9 (2003).
21. Marder VJ. Maximized hemostasis. Thromb Haemost. 87(4):555-6 (2002).
22. Harb TS, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rifai N, Miller Watelet LF, Arora R, Brown MW, Case RB, Dwyer EM Jr, Gillespie JA, Goldstein RE, Greenberg H, Hochman J, Krone RJ, Liang CS, Lichstein E, Little W, Marcus FI, Oakes D,. Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. Am J Cardiol. 89(2):216-21 (2002).
23. Marder VJ, Stewart D. Towards safer thrombolytic therapy. Semin Hematol. 39(3):206-16 (2002).
24. Kaplan KL, Fitzpatrick P, Cox C, Shammas NW, Marder VJ. Use of thrombolytic therapy for acute myocardial infarction: effects of gender and age on treatment rates. J Thromb Thrombolysis. 13(1):21-6 (2002).
